- Home
- LENZ vs OFIX Comparison
LENZ vs OFIX Comparison
Compare LENZ & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- OFIX
- Stock Information
- Founded
- LENZ 2019
- OFIX 1987
- Country
- LENZ United States
- OFIX United States
- Employees
- LENZ N/A
- OFIX N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- OFIX Medical/Dental Instruments
- Sector
- LENZ Health Care
- OFIX Health Care
- Exchange
- LENZ Nasdaq
- OFIX Nasdaq
- Market Cap
- LENZ 729.6M
- OFIX 648.7M
- IPO Year
- LENZ 2021
- OFIX N/A
- Fundamental
- Price
- LENZ $25.71
- OFIX $16.25
- Analyst Decision
- LENZ Strong Buy
- OFIX Strong Buy
- Analyst Count
- LENZ 6
- OFIX 4
- Target Price
- LENZ $38.00
- OFIX $23.33
- AVG Volume (30 Days)
- LENZ 255.9K
- OFIX 219.5K
- Earning Date
- LENZ 03-19-2025
- OFIX 05-06-2025
- Dividend Yield
- LENZ N/A
- OFIX N/A
- EPS Growth
- LENZ N/A
- OFIX N/A
- EPS
- LENZ N/A
- OFIX N/A
- Revenue
- LENZ N/A
- OFIX $799,491,000.00
- Revenue This Year
- LENZ N/A
- OFIX $5.39
- Revenue Next Year
- LENZ $535.40
- OFIX $6.56
- P/E Ratio
- LENZ N/A
- OFIX N/A
- Revenue Growth
- LENZ N/A
- OFIX 7.08
- 52 Week Low
- LENZ $14.42
- OFIX $12.08
- 52 Week High
- LENZ $38.93
- OFIX $20.73
- Technical
- Relative Strength Index (RSI)
- LENZ 54.54
- OFIX 39.32
- Support Level
- LENZ $25.17
- OFIX $16.45
- Resistance Level
- LENZ $27.89
- OFIX $17.00
- Average True Range (ATR)
- LENZ 1.81
- OFIX 0.47
- MACD
- LENZ 0.17
- OFIX -0.02
- Stochastic Oscillator
- LENZ 62.15
- OFIX 42.13
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.